AIKI, NCM

AIkido Pharma Inc. (AIKI)

Price (as of October 24)

6.3USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

VECT

VectivBio Holding AG

-0.16

BDTX

Black Diamond Therapeutics, Inc.

-0.15

CNSP

CNS Pharmaceuticals, Inc.

-0.13

BCEL

Atreca, Inc.

-0.12

BEAM

Beam Therapeutics Inc.

-0.11

GRNAW

GreenLight Biosciences Holdings

-0.11

APM

Aptorum Group Limited

-0.1

MITO

Stealth BioTherapeutics Corp

-0.09

IKNA

Ikena Oncology, Inc.

-0.08

PRLD

Prelude Therapeutics Incorporated

-0.08

Show more

Highest within Industry

Symbol Correlation

ABSI

Absci Corporation

0.24

ACHL

Achilles Therapeutics plc

0.21

ABOS

Acumen Pharmaceuticals, Inc.

0.21

ABCL

AbCellera Biologics Inc.

0.2

ADCT

ADC Therapeutics SA

0.19

RLYB

Rallybio Corporation

0.19

ALGS

Aligos Therapeutics, Inc.

0.17

AKRO

Akero Therapeutics, Inc.

0.17

NVCT

Nuvectis Pharma, Inc.

0.17

GRAY

Graybug Vision, Inc.

0.17

Show more

Profile

Sector:
Healthcare
Industry:
Biotechnology

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company’s pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.